Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease

Background. Crohn’s disease (CD) is a chronic intestinal inflammatory disease. An ideal laboratory marker that can predict the prognosis in terms of relapse of the disease is clinically desirable. Methods. A total of 59 CD patients were enrolled in this study. Enzyme-Linked Immunosorbent Assay (ELIS...

Full description

Saved in:
Bibliographic Details
Main Authors: Jierui Cai, Hong Chen, Meiling Weng, Shuyu Jiang, Jie Gao
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/8536952
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551320332009472
author Jierui Cai
Hong Chen
Meiling Weng
Shuyu Jiang
Jie Gao
author_facet Jierui Cai
Hong Chen
Meiling Weng
Shuyu Jiang
Jie Gao
author_sort Jierui Cai
collection DOAJ
description Background. Crohn’s disease (CD) is a chronic intestinal inflammatory disease. An ideal laboratory marker that can predict the prognosis in terms of relapse of the disease is clinically desirable. Methods. A total of 59 CD patients were enrolled in this study. Enzyme-Linked Immunosorbent Assay (ELISA) was used to quantitatively detect the content of D-lactate (D-LA) and the diamine oxidase (DAO) levels in sera obtained from patients and 28 healthy controls. The correlation between these two biomarkers and disease activity scores was assessed. In addition, the ROC curve was used to evaluate the diagnostic accuracy of these two biomarkers. Results. The levels of D-LA in the serum of CD patients in the active stage and remission stage were 16.08±4.8 mg/L and 11.16±3.17 mg/L, respectively, and the difference was statistically significant (t=4.67, P<0.001). DAO levels were significantly higher in patients with the active stage compared to controls. The levels of D-LA and DAO in CD patients were positively correlated with the disease activity (r=0.68 and 0.53, respectively, P<0.05). The area under the ROC curve (AUC) when CD activity was diagnosed with D-LA and DAO alone was 0.815 and 0.748, respectively. The diagnostic efficacy of the two biomarkers was not significantly different from that of the erythrocyte sedimentation (ESR) and hypersensitive C-reactive protein (CRP) (P>0.05). However, the area under the curve was 0.861 (0.746, 0.937) when the diagnosis was performed using a combination of D-LA, DAO, CRP, and ESR, which was significantly higher than when CRP or ESR were tested alone (P<0.05). Conclusions. D-LA and DAO have a good prognostic value for CD activity. Rational combined use of biomarkers can significantly improve the diagnostic efficiency.
format Article
id doaj-art-6aaf801bcdf74a129a2490cf73796c51
institution Kabale University
issn 1687-6121
1687-630X
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Gastroenterology Research and Practice
spelling doaj-art-6aaf801bcdf74a129a2490cf73796c512025-02-03T06:01:47ZengWileyGastroenterology Research and Practice1687-61211687-630X2019-01-01201910.1155/2019/85369528536952Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s DiseaseJierui Cai0Hong Chen1Meiling Weng2Shuyu Jiang3Jie Gao4School of Medicine, Southeast University, Nanjing, ChinaSchool of Medicine, Southeast University, Nanjing, ChinaSchool of Medicine, Southeast University, Nanjing, ChinaSchool of Medicine, Southeast University, Nanjing, ChinaSchool of Medicine, Southeast University, Nanjing, ChinaBackground. Crohn’s disease (CD) is a chronic intestinal inflammatory disease. An ideal laboratory marker that can predict the prognosis in terms of relapse of the disease is clinically desirable. Methods. A total of 59 CD patients were enrolled in this study. Enzyme-Linked Immunosorbent Assay (ELISA) was used to quantitatively detect the content of D-lactate (D-LA) and the diamine oxidase (DAO) levels in sera obtained from patients and 28 healthy controls. The correlation between these two biomarkers and disease activity scores was assessed. In addition, the ROC curve was used to evaluate the diagnostic accuracy of these two biomarkers. Results. The levels of D-LA in the serum of CD patients in the active stage and remission stage were 16.08±4.8 mg/L and 11.16±3.17 mg/L, respectively, and the difference was statistically significant (t=4.67, P<0.001). DAO levels were significantly higher in patients with the active stage compared to controls. The levels of D-LA and DAO in CD patients were positively correlated with the disease activity (r=0.68 and 0.53, respectively, P<0.05). The area under the ROC curve (AUC) when CD activity was diagnosed with D-LA and DAO alone was 0.815 and 0.748, respectively. The diagnostic efficacy of the two biomarkers was not significantly different from that of the erythrocyte sedimentation (ESR) and hypersensitive C-reactive protein (CRP) (P>0.05). However, the area under the curve was 0.861 (0.746, 0.937) when the diagnosis was performed using a combination of D-LA, DAO, CRP, and ESR, which was significantly higher than when CRP or ESR were tested alone (P<0.05). Conclusions. D-LA and DAO have a good prognostic value for CD activity. Rational combined use of biomarkers can significantly improve the diagnostic efficiency.http://dx.doi.org/10.1155/2019/8536952
spellingShingle Jierui Cai
Hong Chen
Meiling Weng
Shuyu Jiang
Jie Gao
Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease
Gastroenterology Research and Practice
title Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease
title_full Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease
title_fullStr Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease
title_full_unstemmed Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease
title_short Diagnostic and Clinical Significance of Serum Levels of D-Lactate and Diamine Oxidase in Patients with Crohn’s Disease
title_sort diagnostic and clinical significance of serum levels of d lactate and diamine oxidase in patients with crohn s disease
url http://dx.doi.org/10.1155/2019/8536952
work_keys_str_mv AT jieruicai diagnosticandclinicalsignificanceofserumlevelsofdlactateanddiamineoxidaseinpatientswithcrohnsdisease
AT hongchen diagnosticandclinicalsignificanceofserumlevelsofdlactateanddiamineoxidaseinpatientswithcrohnsdisease
AT meilingweng diagnosticandclinicalsignificanceofserumlevelsofdlactateanddiamineoxidaseinpatientswithcrohnsdisease
AT shuyujiang diagnosticandclinicalsignificanceofserumlevelsofdlactateanddiamineoxidaseinpatientswithcrohnsdisease
AT jiegao diagnosticandclinicalsignificanceofserumlevelsofdlactateanddiamineoxidaseinpatientswithcrohnsdisease